The partnering office, JJIPO@MONASH, will be the Victorian headquarters for Johnson & Johnson’s scientific, investment and commercialisation arms to identify medtech projects that can be partnered towards commercialisation.
Australia ranks fifth in the world for life science innovation  and Victoria is home to over 40 per cent of Australia’s ASX-listed health science companies.
Monash President and Vice-Chancellor, Professor Margaret Gardner AO, says the office demonstrated the university’s commitment to supporting new partnerships in biomedical innovation.
‘Monash University has established a world-class reputation for helping to solve some of the most pressing challenges of our time,’ she says. ‘The new Johnson & Johnson Innovation Partnering Office, which expands on our existing partnership with the Johnson & Johnson Family of Companies, greatly advances Victoria’s expertise in biomedical research, fostering new partnerships and innovation to create real and lasting impact worldwide.’
To mark the opening of JJIPO@MONASH, Johnson & Johnson and Monash University have announced the Victorian QuickFire Challenge: Driving Device Innovation, a joint initiative with the Victorian Government, to help kick off the search for new medical device innovation.
The three individuals or teams who submit the most promising medical device solutions in the challenge will be awarded funding from a total grant pool of A$300,000 provided by the Victorian Government to further accelerate their medical device innovations. They will also receive mentoring and special access to the Johnson & Johnson’s global network of experts in development and commercialisation.
JJIPO@Monash is the second partnering office that Johnson & Johnson Innovation has opened in Australia, following the success of the first Johnson & Johnson Innovation Partnering Office in Queensland ( JJIPO@QUT ), which was announced in 2016 in partnership with the Queensland Government and Queensland University of Technology.